STANFORD UNIVERSITY
Leveraging innovative technologies in basic and clinical cancer research
Leveraging innovative technologies in basic and clinical cancer research is a funding opportunity from STANFORD UNIVERSITY, up to 395249, closing August 31, 2028.
Aug 31, 2028
(762d left)Overview
This application requests funds to continue the highly successful Cancer Biology T32 training program at the Stanford University School of Medicine. The current application will present a new vision for this training program, in which the innovative technologies developed and used at Stanford will become a cornerstone…